Feng He
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
- Nephrology 15
- Dialysis and Renal Disease Management 7
- Chronic Kidney Disease and Diabetes 7
- Renal Diseases and Glomerulopathies 4
-
- Renal and Vascular Pathologies 5
- Co-authors
- Paul Aisen (1 shared paper)Martin R. Farlow (1 shared paper)Bruno Vellas (1 shared paper)Xiaoying Sun (1 shared paper)Rachelle S. Doody (1 shared paper)Takeshi Iwatsubo (1 shared paper)Gopalan Sethuraman (1 shared paper)Steven Joffe (1 shared paper)
- Journals
- PLoS ONE (3 papers)Clinical Kidney Journal (2 papers)Clinical & Translational Oncology (1 paper)JAMA Network Open (1 paper)European Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Feng He
49 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Nephrology 303
- Physiology 725
- Biological Psychiatry 69
- Pharmacology 313
- Neurology 131
Countries citing papers authored by Feng He
This map shows the geographic impact of Feng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng He more than expected).
Fields of papers citing papers by Feng He
This network shows the impact of papers produced by Feng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng He. The network helps show where Feng He may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease Hit paper breakdown → | 2013 | 903 |
| 2 | 2012 | 157 | |
| 3 | 2021 | 126 | |
| 4 | 2020 | 108 | |
| 5 | 2013 | 64 | |
| 6 | 2016 | 63 | |
| 7 | 2015 | 56 | |
| 8 | 2014 | 48 | |
| 9 | 2021 | 44 | |
| 10 | 2020 | 38 | |
| 11 | 2016 | 33 | |
| 12 | 2013 | 29 | |
| 13 | 2017 | 28 | |
| 14 | 2020 | 26 | |
| 15 | 2020 | 25 | |
| 16 | 2016 | 24 | |
| 17 | 2020 | 23 | |
| 18 | 2015 | 23 | |
| 19 | 2016 | 22 | |
| 20 | 2015 | 18 |
About Feng He
Feng He is a scholar working on Nephrology, Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 55 papers that have together received 2.1k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (7 papers), Chronic Kidney Disease and Diabetes (7 papers), Renal and Vascular Pathologies (5 papers), Renal Diseases and Glomerulopathies (4 papers), COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Urinary Bladder and Prostate Research (3 papers). The work is most often cited by research in Nephrology (303 citations), Physiology (725 citations), Biological Psychiatry (69 citations), Pharmacology (313 citations) and Neurology (131 citations). Feng He has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Paul Aisen, Martin R. Farlow, Bruno Vellas, Xiaoying Sun, Rachelle S. Doody, Takeshi Iwatsubo, Gopalan Sethuraman, Steven Joffe, Ronald G. Thomas and Karl Kieburtz. Their work appears in journals such as PLoS ONE, Clinical Kidney Journal, Clinical & Translational Oncology, JAMA Network Open and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.